UPDATE 2-Abbott beats Street on strong medical device, generics sales

Oct 18 (Reuters) - Abbott Laboratories' profit and sales topped analysts' estimates on robust sales of medical devices and generic drugs, leading it to raise the high-end of its adjusted earnings forecast for the year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.